Advertisement

Diuretics in Acute Kidney Injury

  • Sagar U. Nigwekar
  • Sushrut S. Waikar
Chapter

Abstract

Outcomes associated with acute kidney injury (AKI) remain poor despite recent clinical advances. Because of limited clinical trial data, the use of diuretics for either prevention or enhancing recovery from AKI remains to be established. Still, diuretic use especially as a “stress test” in patients with AKI remains a common practice. In this chapter, the authors review the literature for diuretic and natriuretic agents in AKI management and discuss related mechanisms, experimental evidence, epidemiology, and randomized controlled trials. Implications for clinical practice regarding when to use these agents in AKI management are addressed.

Keywords

Loop diuretics Mannitol Natriuretic peptides Renal replacement therapy Thiazide diuretics 

References

  1. 1.
    Wang HE, Muntner P, Chertow GM, Warnock DG. Acute kidney injury and mortality in hospitalized patients. Am J Nephrol. 2012;35:349–55.CrossRefGoogle Scholar
  2. 2.
    Okusa MD, Molitoris BA, Palevsky PM, Chinchilli VM, Liu KD, Cheung AK, Weisbord SD, Faubel S, Kellum JA, Wald R, Chertow GM, Levin A, Waikar SS, Murray PT, Parikh CR, Shaw AD, Go AS, Chawla LS, Kaufman JS, Devarajan P, Toto RM, Hsu CY, Greene TH, Mehta RL, Stokes JB, Thompson AM, Thompson BT, Westenfelder CS, Tumlin JA, Warnock DG, Shah SV, Xie Y, Duggan EG, Kimmel PL, Star RA. Design of clinical trials in acute kidney injury: a report from an NIDDK Workshop—prevention trials. Clin J Am Soc Nephrol. 2012;7(5):851.CrossRefGoogle Scholar
  3. 3.
    Bagshaw SM, Bellomo R, Kellum JA. Oliguria, volume overload, and loop diuretics. Crit Care Med. 2008;36:S172–8.CrossRefGoogle Scholar
  4. 4.
    Mehta RL, Pascual MT, Soroko S, Chertow GM, PICARD Study Group. Diuretics, mortality, and nonrecovery of renal function in acute renal failure. JAMA. 2002;288:2547–53.CrossRefGoogle Scholar
  5. 5.
    Nigwekar SU, Waikar SS. Diuretics in acute kidney injury. Semin Nephrol. 2011;31:523–34.CrossRefGoogle Scholar
  6. 6.
    Bagshaw SM, Delaney A, Jones D, Ronco C, Bellomo R. Diuretics in the management of acute kidney injury: a multinational survey. Contrib Nephrol. 2007;156:236–49.CrossRefGoogle Scholar
  7. 7.
    Shankar SS, Brater DC. Loop diuretics: from the Na-K-2Cl transporter to clinical use. Am J Physiol Renal Physiol. 2003;284:F11–21.CrossRefGoogle Scholar
  8. 8.
    Bayati A, Nygren K, Kallskog O, Wolgast M. The effect of loop diuretics on the long-term outcome of post-Ischaemic acute renal failure in the rat. Acta Physiol Scand. 1990;139:271–9.CrossRefGoogle Scholar
  9. 9.
    Tenstad O, Williamson HE. Effect of furosemide on local and zonal glomerular filtration rate in the rat kidney. Acta Physiol Scand. 1995;155:99–107.CrossRefGoogle Scholar
  10. 10.
    Bak M, Shalmi M, Petersen JS, Poulsen LB, Christensen S. Effects of angiotensin-converting enzyme inhibition on renal adaptations to acute furosemide administration in conscious rats. J Pharmacol Exp Ther. 1993;266:33–40.PubMedGoogle Scholar
  11. 11.
    De Torrente A, Miller PD, Cronin RE, Paulsin PE, Erickson AL, Schrier RW. Effects of furosemide and acetylcholine in norepinephrine-induced acute renal failure. Am J Phys. 1978;235:F131–6.Google Scholar
  12. 12.
    Brater DC. Resistance to diuretics: emphasis on a pharmacological perspective. Drugs. 1981;22:477–94.CrossRefGoogle Scholar
  13. 13.
    Brater DC. Diuretic therapy. N Engl J Med. 1998;339:387–95.CrossRefGoogle Scholar
  14. 14.
    Wang DJ, Gottlieb SS. Diuretics: still the mainstay of treatment. Crit Care Med. 2008;36:S89–94.CrossRefGoogle Scholar
  15. 15.
    Chawla LS, Davison DL, Brasha-Mitchell E, Koyner JL, Arthur JM, Shaw AD, Tumlin JA, Trevino SA, Kimmel PL, Seneff MG. Development and standardization of a furosemide stress test to predict the severity of acute kidney injury. Crit Care. 2013;17:R207.CrossRefGoogle Scholar
  16. 16.
    Chawla LS. The furosemide stress test to predict renal function after continuous renal replacement therapy. Authors’ response. Crit Care. 2014;18:429.CrossRefGoogle Scholar
  17. 17.
    Koyner JL, Davison DL, Brasha-Mitchell E, Chalikonda DM, Arthur JM, Shaw AD, Tumlin JA, Trevino SA, Bennett MR, Kimmel PL, Seneff MG, Chawla LS. Furosemide stress test and biomarkers for the prediction of AKI severity. J Am Soc Nephrol. 2015;26:2023–31.CrossRefGoogle Scholar
  18. 18.
    Paton RR, Kane RE. Long-term diuretic therapy with metolazone of renal failure and the nephrotic syndrome. J Clin Pharmacol. 1977;17:243–51.CrossRefGoogle Scholar
  19. 19.
    Bosch X, Poch E, Grau JM. Rhabdomyolysis and acute kidney injury. N Engl J Med. 2009;361:62–72.CrossRefGoogle Scholar
  20. 20.
    Higa EM, Dib SA, Martins JR, Campos L, Homsi E. Acute renal failure due to rhabdomyolysis in diabetic patients. Ren Fail. 1997;19:289–93.CrossRefGoogle Scholar
  21. 21.
    Homsi E, Barreiro MF, Orlando JM, Higa EM. Prophylaxis of acute renal failure in patients with rhabdomyolysis. Ren Fail. 1997;19:283–8.CrossRefGoogle Scholar
  22. 22.
    Allgren RL, Marbury TC, Rahman SN, Weisberg LS, Fenves AZ, Lafayette RA, Sweet RM, Genter FC, Kurnik BR, Conger JD, Sayegh MH. Anaritide in acute tubular necrosis. Auriculin Anaritide Acute Renal Failure Study Group. N Engl J Med. 1997;336:828–34.CrossRefGoogle Scholar
  23. 23.
    Weisberg LS, Allgren RL, Genter FC, Kurnik BR. Cause of acute tubular necrosis affects its prognosis. The Auriculin Anaritide Acute Renal Failure Study Group. Arch Intern Med. 1997;157:1833–8.CrossRefGoogle Scholar
  24. 24.
    Uchino S, Doig GS, Bellomo R, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Nacedo E, Gibney N, Tolwani A, Ronco C, Kellum JA. Beginning, ending supportive therapy for the kidney I: diuretics and mortality in acute renal failure. Crit Care Med. 2004;32:1669–77.CrossRefGoogle Scholar
  25. 25.
    Jones SL, Martensson J, Glassford NJ, Eastwood GM, Bellomo R. Loop diuretic therapy in the critically ill: a survey. Crit Care Resusc. 2015;17:223–6.PubMedGoogle Scholar
  26. 26.
    Dorman HR, Sondheimer JH, Cadnapaphornchai P. Mannitol-induced acute renal failure. Medicine (Baltimore). 1990;69:153–9.CrossRefGoogle Scholar
  27. 27.
    Fang L, You H, Chen B, Xu Z, Gao L, Liu J, Xie Q, Zhou Y, Gu Y, Lin S, Ding F. Mannitol is an independent risk factor of acute kidney injury after cerebral trauma: a case-control study. Ren Fail. 2010;32:673–9.CrossRefGoogle Scholar
  28. 28.
    Solomon R, Werner C, Mann D, D’Elia J, Silva P. Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med. 1994;331:1416–20.CrossRefGoogle Scholar
  29. 29.
    Mahesh B, Yim B, Robson D, Pillai R, Ratnatunga C, Pigott D. Does furosemide prevent renal dysfunction in high-risk cardiac surgical patients? Results of a double-blinded prospective randomised trial. Eur J Cardiothorac Surg. 2008;33:370–6.CrossRefGoogle Scholar
  30. 30.
    Majumdar SR, Kjellstrand CM, Tymchak WJ, Hervas-Malo M, Taylor DA, Teo KK. Forced euvolemic diuresis with mannitol and furosemide for prevention of contrast-induced nephropathy in patients with CKD undergoing coronary angiography: a randomized controlled trial. Am J Kidney Dis. 2009;54:602–9.CrossRefGoogle Scholar
  31. 31.
    Shilliday IR, Quinn KJ, Allison ME. Loop diuretics in the management of acute renal failure: a prospective, double-blind, placebo-controlled, randomized study. Nephrol Dial Transplant. 1997;12:2592–6.CrossRefGoogle Scholar
  32. 32.
    Brown CB, Ogg CS, Cameron JS. High dose frusemide in acute renal failure: a controlled trial. Clin Nephrol. 1981;15:90–6.PubMedGoogle Scholar
  33. 33.
    Cantarovich F, Rangoonwala B, Lorenz H, Verho M, Esnault VL, High-Dose Flurosemide in Acute Renal Failure Study Group. High-dose furosemide for established ARF: A prospective, randomized, double-blind, placebo-controlled, multicenter trial. Am J Kidney Dis. 2004;44:402–9.CrossRefGoogle Scholar
  34. 34.
    Cantarovich F, Locatelli A, Fernandez JC, Perez Loredo J, Cristhot J, Debenedetti L. [Treatment of urinary infections with antibiotics and high doses of furosemide]. Rev Clin Esp. 1971;123:59–62.Google Scholar
  35. 35.
    Kleinknecht D, Ganeval D, Gonzalez-Duque LA, Fermanian J. Furosemide in acute oliguric renal failure. A controlled trial. Nephron. 1976;17:51–8.CrossRefGoogle Scholar
  36. 36.
    Van Der Voort PH, Boerma EC, Koopmans M, Zandberg M, De Ruiter J, Gerritsen RT, Egbers PH, Kingma WP, Kuiper MA. Furosemide does not improve renal recovery after hemofiltration for acute renal failure in critically ill patients: a double blind randomized controlled trial. Crit Care Med. 2009;37:533–8.CrossRefGoogle Scholar
  37. 37.
    Kunt AT, Akgun S, Atalan N, Bitir N, Arsan S. Furosemide infusion prevents the requirement of renal replacement therapy after cardiac surgery. Anadolu Kardiyol Derg. 2009;9:499–504.PubMedGoogle Scholar
  38. 38.
    Bagshaw SM, Delaney A, Haase M, Ghali WA, Bellomo R. Loop diuretics in the management of acute renal failure: a systematic review and meta-analysis. Crit Care Resusc. 2007;9:60–8.Google Scholar
  39. 39.
    Ho KM, Sheridan DJ. Meta-analysis of frusemide to prevent or treat acute renal failure. BMJ. 2006;333:420.CrossRefGoogle Scholar
  40. 40.
    Yang B, Xu J, Xu F, Zou Z, Ye C, Mei C, Mao Z. Intravascular administration of mannitol for acute kidney injury prevention: a systematic review and meta-analysis. PLoS One. 2014;9:e85029.CrossRefGoogle Scholar
  41. 41.
    Gu G, Zhang Y, Lu R, Cui W. Additional furosemide treatment beyond saline hydration for the prevention of contrast-induced nephropathy: a meta-analysis of randomized controlled trials. Int J Clin Exp Med. 2015;8:387–94.PubMedPubMedCentralGoogle Scholar
  42. 42.
    Nigwekar SU, Hix JK. The role of natriuretic peptide administration in cardiovascular surgery-associated renal dysfunction: a systematic review and meta-analysis of randomized controlled trials. J Cardiothorac Vasc Anesth. 2009;23:151–60.CrossRefGoogle Scholar
  43. 43.
    Nigwekar SU, Navaneethan SD, Parikh CR, Hix JK. Atrial natriuretic peptide for preventing and treating acute kidney injury. Cochrane Database Syst Rev. 2009;(4):CD006028.Google Scholar
  44. 44.
    Nigwekar SU, Navaneethan SD, Parikh CR, Hix JK. Atrial natriuretic peptide for management of acute kidney injury: a systematic review and meta-analysis. Clin J Am Soc Nephrol. 2009;4:261–72.CrossRefGoogle Scholar
  45. 45.
    Nigwekar SU, Kulkarni H, Thakar CV. Natriuretic peptides in the management of solid organ transplantation associated acute kidney injury: a systematic review and meta-analysis. Int J Nephrol. 2013;2013:949357.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Medicine/NephrologyMassachusetts General HospitalBostonUSA
  2. 2.Division of Renal MedicineBrigham and Women’s Hospital, Harvard Medical SchoolBostonUSA

Personalised recommendations